Investors

Insider Transactions

Date Name Title Type Sorted Descending Shares Traded Price Range
Sep 7, 2011 brown michael s Director Option Execute 5,000 9.17
Sep 8, 2011 brown michael s Director Option Execute 5,000 9.17
Sep 21, 2011 brown michael s Director Option Execute 5,000 9.17
Mar 17, 2011 gilman alfred g Director Option Execute 30,000 18.80 - 28.81
Aug 7, 2012 gilman alfred g Director Option Execute 15,000 15.80
Feb 14, 2012 gilman alfred g Director Option Execute 30,000 9.17 - 15.01
May 27, 2010 gilman alfred g Director Option Execute 5,000 25.43
Jan 21, 2009 gilman alfred g Director Option Execute 10,000 7.66
Feb 20, 2008 gilman alfred g Director Option Execute 10,000 7.91
May 6, 2013 gilman alfred g Director Option Execute 30,000 19.69 - 23.84
Jan 14, 2014 gilman alfred g Director Option Execute 5,000 18.61
Feb 21, 2014 gilman alfred g Director Option Execute 5,000 18.61
Feb 11, 2014 gilman alfred g Director Option Execute 5,000 18.61
Nov 24, 2014 gilman alfred g Director Option Execute 40,000 24.41 - 57.11
Aug 6, 2015 gilman alfred g Director Option Execute 5,000 57.11
Oct 23, 2014 goldberg murray a Officer Option Execute 60,000 30.63
Dec 16, 2014 goldberg murray a Officer Option Execute 3,264 30.63
Feb 20, 2014 goldberg murray a Officer Option Execute 50,652 30.63 - 79.53
Feb 24, 2014 goldberg murray a Officer Option Execute 30,227 52.03 - 90.07
Dec 18, 2013 goldberg murray a Officer Option Execute 4,705 21.25
Showing 181-200 of 1021 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)